… ProQR Announces Expert Perspectives Conference Call Series … & CAMBRIDGE, Mass., June 12, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … Drs. Girach and Koenekoop will also discuss QR-421a, ProQR’s investigational therapy for patients with Usher …
… ProQR to Present at Upcoming Investor Conferences … Mass., Nov. 13, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … will be accessible from the ‘Investors’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …
LEIDEN, Netherlands, Sept. 18, 2014 (GLOBE NEWSWIRE) -- ProQR Therapeutics today announced the pricing of its initial public offering of 7,500,000 ordinary shares at an initial public offering price of $13.00 per ordinary share.
… ProQR to Participate in Upcoming Investor Conferences LEIDEN, … & CAMBRIDGE, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a … 30 days following the presentation date. About ProQRProQR Therapeutics is dedicated to changing lives …
… ProQR Therapeutics Added to NASDAQ Biotechnology Index … & CAMBRIDGE, Mass., Dec. 24, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … and share volume requirements among other criteria. About ProQRProQR Therapeutics is dedicated to changing lives …
… ProQR Announces Proposed Public Offering of Ordinary Shares … LEIDEN, the Netherlands, Nov. 13, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a biopharmaceutical … public offering. All of the shares are being offered by ProQR. In addition, in the public offering, ProQR expects to …